“…Caffeic acid, PLCA, CAPE, and nitro-CAPE derivatives have shown a very high potential for preventing and attenuating tissue damage caused by ischemia/reperfusion (I/R) injury in many organs in vivo and in vitro , including the myocardium ( Ozer et al, 2004 ; Cagli et al, 2005 ; Huang et al, 2005 ; Parlakpinar et al, 2005 ; Tan et al, 2005 ; Özeren et al, 2005 ; Ince et al, 2006 ; Ho et al, 2013 ; Castellano et al, 2016 ), skeletal muscle ( Cagli et al, 2005 ; Ozyurt et al, 2006 , 2007 ; Andrade-Silva et al, 2009 ), brain ( Irmak et al, 2001 ; Tsai et al, 2006 ; Altuǧ et al, 2008 ), spinal cord ( Ilhan et al, 1999 ), liver ( Feng et al, 2008 ; Saavedra-Lopes et al, 2008 ), kidney ( Irmak et al, 2001 ; Gurel et al, 2004 ; Ozer et al, 2005a ; Migliori et al, 2015 ), intestine ( Koltuksuz et al, 1999 ; Sato et al, 2011 ; Teke et al, 2012 , 2013 ), retina ( Shi et al, 2010 ), ovary ( Celli et al, 2004 ; Kart et al, 2009 ), testes ( Koltuksuz et al, 2000 ; Eşrefoglu et al, 2005 ; Atik et al, 2006 ), and skin flaps ( Aydogan et al, 2007 ; Yeǧin et al, 2020 ). Nearly all the studies conducted on the beneficial properties of these compounds on I/R injury agree that they are due to their potent ROS scavenging, antioxidant and anti-inflammatory activities.…”